C.D.C. Panel Will Discuss Blood Clot Risk Linked to J.&J.’s Vaccine
Expert advisers to the Centers for Disease Control and Prevention will meet on Thursday to discuss what federal health officials see as a concerning increase in the rates of a rare but serious blood clotting disorder linked to Johnson & Johnson’s coronavirus vaccine. The Advisory Committee on Immunization Practices will see new data at the…